Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02537613 | A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia | ||
| NCT00308178 | Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer | ||
| NCT00398710 | A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia | ||
| NCT04434040 | Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) | ||
| NCT04239040 | GVAX Plus Checkpoint Blockade in Neuroblastoma | ||
| NCT00142168 | CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia | ||
| NCT01065662 | AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | ||
| NCT00116220 | Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer | ||
| NCT01983410 | A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma | ||
| NCT03203473 | Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) | ||
| NCT05922761 | BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) | ||
| NCT04416568 | Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers | ||
| NCT00577642 | Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates | ||
| NCT00317603 | Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients | ||
| NCT03717480 | Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies | ||
| NCT03392090 | SHARE (Sharing Goals and Preferences) Study | ||
| NCT00140504 | Preventing Adverse Drug Events With PatientSite | ||
| NCT05918263 | Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial | ||
| NCT01753089 | Dendritic Cell Activating Scaffold in Melanoma | ||
| NCT00458237 | Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer | ||
| NCT02086175 | A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma | ||
| NCT01665937 | STA-9090 in Patients With Advanced Hepatocellular Cancer | ||
| NCT00630344 | RAD001 and Bicalutamide for Androgen Independent Prostate Cancer | ||
| NCT04406272 | VB-111 in Surgically Accessible Recurrent/Progressive GBM | ||
| NCT03858712 | EHR-embedded OCDT in Breast or GI Cancer | ||
| NCT01340300 | Exercise and Metformin in Colorectal and Breast Cancer Survivors | ||
| NCT03835819 | A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) | ||
| NCT00448721 | A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer | ||
| NCT01400685 | Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL | ||
| NCT03367247 | BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal | ||
| NCT01012609 | External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas | ||
| NCT06422455 | Access to Genetic Testing in Underserved Patients With Cancer | ||
| NCT00483262 | Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma | ||
| NCT02022982 | PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors | ||
| NCT03534323 | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS | ||
| NCT02248662 | Impact of Radiation Therapy on Breast Conservation in DCIS | ||
| NCT01191697 | CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer | ||
| NCT00165282 | Mindfulness Meditation in Bone Marrow Transplantation | ||
| NCT00136409 | A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) | ||
| NCT00005627 | Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | ||
| NCT00321646 | Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy | ||
| NCT00005988 | Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy | ||
| NCT01659203 | Proton or Photon RT for Retroperitoneal Sarcomas | ||
| NCT04855695 | Avo In R/R And Previously Untreated MCL | ||
| NCT01339039 | Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma | ||
| NCT03294694 | Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer | ||
| NCT00808639 | Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma | ||
| NCT03850912 | Symptom Management Implementation of Patient Reported Outcomes in Oncology | ||
| NCT04481672 | Intravenous Magnesium in Patients Receiving Cisplatin | ||
| NCT00147212 | ET 743 (Yondelis) in Men With Advanced Prostate Cancer |
